This inventor holds 2 USPTO granted patents and 1 published patent application and 2 EPO patents. Top assignees: Boehringer Ingelheim International Gmbh, Dr. Karl Thomae Gmbh. Active years: 2000-2022.
Company Filing History:

Years Active: 2000-2022
Title: The Innovations of Peter Schorn
Introduction
Peter Schorn is a notable inventor based in Langenau, Germany. He has made significant contributions to the field of cell culture technology, holding a total of 2 patents. His work focuses on improving mammalian cell culture processes, which are essential in various biotechnological applications.
Latest Patents
One of Peter Schorn's latest patents is related to a cell culture medium. This invention provides a basal cell culture medium and a feed medium with novel amino acid ratios and/or iron choline citrate as an iron carrier. These innovations result in improved performance of mammalian cell culture processes, such as CHO cultivation and protein production processes, particularly in increased product titer, for example, of monoclonal antibodies. Additionally, he has developed methods for culturing mammalian cells and producing a protein of interest using the aforementioned basal cell culture medium and optionally the feed medium. Another significant patent is a sampling system designed for use in the analysis of biological processes.
Career Highlights
Throughout his career, Peter Schorn has worked with reputable companies, including Dr. Karl Thomae GmbH and Boehringer Ingelheim International GmbH. His experience in these organizations has contributed to his expertise in the field of biotechnology and cell culture.
Collaborations
Peter has collaborated with several professionals in his field, including Christoph Clemens and Hans Voigt. These collaborations have likely enhanced his research and development efforts, leading to innovative solutions in cell culture technology.
Conclusion
Peter Schorn's contributions to the field of cell culture are noteworthy, with his patents reflecting significant advancements in the industry. His work continues to influence the development of biotechnological processes, showcasing the importance of innovation in this area.